Effects of Alirocumab on Cardiovascular and Metabolic Outcomes After ACS in Patients With or Without Diabetes

The Lancet
Aug 21, 2019

After a recent acute coronary syndrome, alirocumab treatment did not increase the risk of new-onset diabetes.

Read More

Acute Retinopathy in Pseudoxanthoma Elasticum

JAMA
Aug 21, 2019

Acute retinopathy in patients with PXE may occur, with symptoms ranging from short-term, reversible alterations to irreversible vision loss.

Read More

Ad Hoc Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease

Science Direct
Aug 20, 2019

Ad hoc PCI is extremely common among US patients with stable CAD and is associated with lower bleeding risk but no differences in risks of AKI or mortality compared with non–ad hoc PCI.

Read More

FDA Approves First of its Kind Device to Treat Pediatric Patients with Progressive Idiopathic Scoliosis

FDA
Aug 20, 2019

The device, called The Tether, is intended to treat growing children and adolescents whose spinal curves are approaching or have reached the range where surgical treatment is an option.

Read More

FDA Approved Oncology Drug - Rozlytrek (Entrectinib)

FDA
Aug 19, 2019

FDA approves third oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor

Read More

FDA Approved Drug for Tuberculosis (TB)

FDA
Aug 19, 2019

FDA approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs

Read More

Neoadjuvant Letrozole Plus Taselisib Versus Letrozole Plus Placebo in Postmenopausal Women with Oestrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer (LORELEI)

The Lancet
Aug 16, 2019

The increase in the proportion of patients who achieved an objective response from the addition of taselisib to endocrine therapy in a neoadjuvant setting is consistent with the clinical benefit observed in hormone receptor-positive, HER2-negative, metastatic breast cancer.

Read More

FDA Warns Consumers About the Dangerous and Potentially Life Threating Side Effects of Miracle Mineral Solution

FDA
Aug 16, 2019

FDA warns not to purchase or drink a product sold online as a medical treatment due to a recent rise in reported health issues.

Read More

Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016

JAMA
Aug 14, 2019

It appears that the diabetes care cascade in the United States has not significantly improved between 2005 and 2016.

Read More

Self-Managed, Computerised Speech and Language Therapy for Patients with Chronic Aphasia Post-Stroke

The Lancet
Aug 13, 2019

CSLT plus usual care resulted in a clinically significant improvement in personally relevant word finding but did not result in an improvement in conversation.

Read More